Hwail Pharm Co.,Ltd. is engaged in manufacturing and distribution of raw materials used in pharmaceutical production. The company offers aceclofenac, lornoxicam, triflusal, gallamine tri-ethyl iodide, acemetacin, levosulpiride, alibendol, talniflumate, topiramate, oxatomide and others used as expectorants, cough remedies, antispasmodics, analgesics, anti-inflammatories and others. Hwail Pharm Co.,Ltd. also provides finished formulations including injection products such as ceftazidime, cefoperazone, cefotaxime, cefaclor, cefatrizine and others. The company's headquarters is located in Hwaseong, Gyeonggi-do Province, South Korea. Hwail Pharm Co.,Ltd. was incorporated in 1980.
Headquarters
904-7 Sangsin-Ri, Hyangnam-Myeon, Hwasung-Si
Hwaseong; Gyeonggi;
Postal Code: 135-080
Contact Details: Purchase the Hwail Pharm. Co.,Ltd. report to view the information.
Website: http://www.hwail.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service